![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Wu, Liya; Piotrowski, Katja; Rau, Tiina; Waldmann, Elisa; Broedl, Uli C.; Demmelmair, Hans; Koletzko, Berthold; Stark, Renee G.; Nagel, Jutta M.; Mantzoros, Christos S. und Parhofer, Klaus G.
(2014):
Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.
In: Metabolism: clinical and experimental, Bd. 63, Nr. 3: S. 382-391
Broedl, Uli C.; Lebherz, Corinna; Lehrke, Michael; Stark, Renee; Greif, Martin; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Parhofer, Klaus G. und Leber, Alexander W.
(2009):
Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
In: PLOS ONE 4(3), e4733 [PDF, 112kB]
In: PLOS ONE 4(3), e4733 [PDF, 112kB]
Lehrke, Michael; Greif, Martin; Broedl, Uli C.; Lebherz, Corinna; Laubender, Rüdiger P.; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Steinbeck, Gerhard; Leber, Alexander W. und Parhofer, Klaus G.
(2009):
MMP-1 serum levels predict coronary atherosclerosis in humans.
In: Cardiovascular Diabetology
8:50
[PDF, 308kB]
Lehrke, Michael; Broedl, Uli C.; Biller-Friedmann, Ingeborg M.; Vogeser, Michael; Henschel, Volkmar; Nassau, Kirsten; Goeke, Burkhard; Kilger, Erich und Parhofer, Klaus G.
(2008):
Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.
In: Critical Care
12:R157
[PDF, 320kB]
Broedl, Uli C.; Lehrke, Michael; Fleischer-Brielmaier, Elisabeth; Tietz, Anne B.; Nagel, Jutta M.; Göke, Burkhard; Lohse, Peter und Parhofer, Klaus G.
(2006):
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
In: Cardiovascular Diabetology
5:11
[PDF, 284kB]